It’s my spleen - I want royalties.
“When Moore’s spleen was removed to treat a rare form of leukemia, his University of California doctor patented a cell line taken from his organ, without Moore’s knowledge or permission. The longterm market value of the patent has been estimated at roughly $3 billion, and Moore’s doctor received $3 million in stocks from Genetics Institute, the firm that marketed and developed a drug based on the patent.”
Moore sued and lost.
From Freedom of Expression ®, Overzealous Copyright Bozos
and Other Enemies of Creativity (PDF), by Kembrew McLeod.